Internal documents and former company executives reveal how Cigna doctors reject patients’ claims without opening their files. “We literally click and submit,” one former company doctor said.

A new law will grant parole hearings for prisoners given life or long sentences as children. But our reporting showed that New Mexico officials weren’t aware of at least 21 “juvenile lifers” in the state’s custody.

The city’s prosecution of a former student comes as the state considers a ban on ticketing students at school. The case is headed to a jury trial.

A string of disasters have decimated oyster populations, with far-reaching impacts on the health of the Mississippi Sound. The state’s yearslong efforts to restore the reefs have fallen short.

In the letters, Jordan asserted that the schools may have contributed to the Biden administration’s “censorship regime by advising on so-called misinformation.”

In previously unreported videos from a closed-door Teneo Network conference, Florida's Republican governor takes his anti-big tech rhetoric beyond what he has said publicly.

After a ProPublica investigation, RealPage answered questions from lawmakers about its product. In response, the senators sent a letter to the Justice Department.

In previously unreleased interviews, police told investigators they were cowed by the Uvalde shooter’s military-style rifle. This drove their decision to wait for a Border Patrol SWAT team to engage him, which took more than an hour.

Questions about the origins and ownership of some Asian artifacts in a key collection at the Art Institute of Chicago have cast doubt on the museum’s commitment to keeping its galleries free of stolen antiquities.

Officials in Houston County, Georgia, said gender-affirming surgery for sheriff’s deputy Anna Lange was too costly. They spent more than $1 million on private lawyers in a fight to keep transition-related care from being covered by their health plan.

Never-before-seen IRS records show that CEOs are sometimes making multimillion-dollar bets on the stocks of direct competitors and partners — and doing so with exquisite timing.